← FDA DRUG APPROVALS

FDA ANDA · ANDA077123

HALOBETASOL PROPIONATE

Sponsor: PADAGIS ISRAEL

APPLICATION
ANDA077123
TYPE
ANDA
ORIGINAL APPROVAL
2004-12-16
LATEST ACTION
2004-12-16
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

HALOBETASOL PROPIONATEPrescription
HALOBETASOL PROPIONATE 0.05% · CREAM · TOPICAL

Approval history

2004-12-16OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →